168 related articles for article (PubMed ID: 31719831)
1. Identification of Dysregulated Competitive Endogenous RNA Networks Driven by Copy Number Variations in Malignant Gliomas.
Xu J; Hou X; Pang L; Sun S; He S; Yang Y; Liu K; Xu L; Yin W; Xu C; Xiao Y
Front Genet; 2019; 10():1055. PubMed ID: 31719831
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated ceRNA network modulated by copy number variation-driven lncRNAs in breast cancer: A comprehensive analysis.
Zhu X; Song J; Wang M; Wang X; Lv L
J Gene Med; 2023 Mar; 25(3):e3471. PubMed ID: 36525372
[TBL] [Abstract][Full Text] [Related]
3. Identification of a ceRNA Network Driven by Copy Number Variations in Esophageal Cancer.
Xu G; Wang H; Zhuang Y; Lin Q; Li Y; Cai Z; Lin G; Liu W
J Nippon Med Sch; 2023; 90(6):426-438. PubMed ID: 38246614
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Effect of Differentially Expressed Long Non-coding RNAs Driven by Copy Number Variation on Competing Endogenous RNA Network by Mining Lung Adenocarcinoma Data.
Hu H; Xu H; Lu F; Zhang J; Xu L; Xu S; Jiang H; Zeng Q; Chen E; He Z
Front Cell Dev Biol; 2020; 8():627436. PubMed ID: 33585468
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of a long non-coding RNA-mediated competitive endogenous RNA network in glioblastoma multiforme.
Long S; Li G
Exp Ther Med; 2019 Aug; 18(2):1081-1090. PubMed ID: 31316603
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the Functional Mechanisms of Somatic Copy-Number Alterations Based on Dysregulated ceRNA Networks across Cancers.
Ping Y; Zhou Y; Hu J; Pang L; Xu C; Xiao Y
Mol Ther Nucleic Acids; 2020 Sep; 21():464-479. PubMed ID: 32668393
[TBL] [Abstract][Full Text] [Related]
8. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
Zhang K; Li Q; Kang X; Wang Y; Wang S
Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
[TBL] [Abstract][Full Text] [Related]
9. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
[TBL] [Abstract][Full Text] [Related]
10. Comparison and analysis of lncRNA-mediated ceRNA regulation in different molecular subtypes of glioblastoma.
Li Q; Yu Q; Ji J; Wang P; Li D
Mol Omics; 2019 Dec; 15(6):406-419. PubMed ID: 31584593
[TBL] [Abstract][Full Text] [Related]
11. Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma.
Yuan Y; Jiaoming L; Xiang W; Yanhui L; Shu J; Maling G; Qing M
J Neurooncol; 2018 May; 137(3):493-502. PubMed ID: 29335913
[TBL] [Abstract][Full Text] [Related]
12. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
Luo Q; Cui M; Deng Q; Liu J
Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192
[TBL] [Abstract][Full Text] [Related]
14. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma.
Zhao R; Li FQ; Tian LL; Shang DS; Guo Y; Zhang JR; Liu M
Funct Integr Genomics; 2019 Jan; 19(1):109-121. PubMed ID: 30128795
[TBL] [Abstract][Full Text] [Related]
16. Construction and Investigation of a lncRNA-Associated ceRNA Regulatory Network in Cholangiocarcinoma.
Long J; Xiong J; Bai Y; Mao J; Lin J; Xu W; Zhang H; Chen S; Zhao H
Front Oncol; 2019; 9():649. PubMed ID: 31448221
[No Abstract] [Full Text] [Related]
17. Comprehensive Transcriptomic Analysis and Experimental Validation Identify lncRNA HOXA-AS2/miR-184/COL6A2 as the Critical ceRNA Regulation Involved in Low-Grade Glioma Recurrence.
Chen PY; Li XD; Ma WN; Li H; Li MM; Yang XY; Li SY
Onco Targets Ther; 2020; 13():4999-5016. PubMed ID: 32581558
[TBL] [Abstract][Full Text] [Related]
18. The Functional Characterization of Epigenetically Related lncRNAs Involved in Dysregulated CeRNA-CeRNA Networks Across Eight Cancer Types.
Xu D; Wang L; Pang S; Cao M; Wang W; Yu X; Xu Z; Xu J; Wang H; Lu J; Li K
Front Cell Dev Biol; 2021; 9():649755. PubMed ID: 34222227
[TBL] [Abstract][Full Text] [Related]
19. Integrative Analysis of Dysregulated lncRNA-Associated ceRNA Network Reveals Functional lncRNAs in Gastric Cancer.
Liu H; Zhang Z; Wu N; Guo H; Zhang H; Fan D; Nie Y; Liu Y
Genes (Basel); 2018 Jun; 9(6):. PubMed ID: 29912172
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Dysregulated lncRNA-Associated ceRNA Network Reveals Novel lncRNAs With ceRNA Activity as Epigenetic Diagnostic Biomarkers for Osteoporosis Risk.
Zhang M; Cheng L; Zhang Y
Front Cell Dev Biol; 2020; 8():184. PubMed ID: 32296700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
